Skip to main content
Clinical Trials/ISRCTN15728885
ISRCTN15728885
Completed
未知

Feasibility of a self-management intervention for improving mobility for patients following stroke in the community

niversity of Birmingham0 sites24 target enrollmentSeptember 30, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Birmingham
Enrollment
24
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2021
End Date
February 3, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Individuals will be eligible to participate in the study if they:
  • 1\. Are adults (18 years to 99 years)
  • 2\. Have had a diagnosis of a first stroke
  • 3\. Are within the first 3 months post\-discharge from the hospital. This will be extended to participants who have had a stroke within the past 6 months
  • 4\. With Functional Ambulation Category (FAC) 2\. This means that the person is at least able to walk with a maximum of one person assistance, with or without a gait aid (Mehrholz et al., 2007\)
  • 5\. Have cognitive capacity that allows them to communicate and consent to participate in the study. The Montreal Cognition assessment (MoCA) (Cumming et al., 2013\) and the FAC will be used for screening. Moreover, clinicians will be involved in determining patient’s ability to participate prior to approaching any participant about this study
  • 6\. Can understand English. However, the feasibility of including participants who speak Punjabi or Urdu will be explored using translated information sheets and interpreters when possible using family members who speak English
  • 7\. Have access to a suitable device that can launch the ZOOM Programme

Exclusion Criteria

  • Patients will be excluded if they:
  • 1\. Are unable to participate or unable to give consent to participate in the programme due to marked cognitive impairment
  • 2\. Suffer from severe cardiopulmonary diseases or severe arthritis or have other major co\-morbidities, which might be a risk for community walking
  • 3\. Have severe aphasia
  • 4\. Have severe spasticity or fatigue post stroke

Outcomes

Primary Outcomes

Not specified

Similar Trials